Drug Tariff News
MHRA Class 2 Drug Alert: Tredaptive modified-release tablets 
The MHRA have issued a class 2 drug alert for:
Merck Sharp & Dohme Ltd - Tredaptive modified-release tablets - Nicotinic acid and Laropiprant - EL (13)A/02
To view the alert please visit the MHRA website.
Posted 21 January 2013